SciELO - Scientific Electronic Library Online

 
vol.70 issue4Comparative analysis between sclera treated with glycerin and sclera treated with gamma irradiation, alkali and glycerin in the reconstruction of anophthalmic socket: experimental study in rabbitsUltrastructural evaluation of mitomycin C toxic effects on the ciliary epithelium of normal rabbits eyes with and without aqueous humor suppressant treatment author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Arquivos Brasileiros de Oftalmologia

Print version ISSN 0004-2749

Abstract

PINHEIRO JR., Manuel Neuzimar et al. Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sjögren's syndrome patients. Arq. Bras. Oftalmol. [online]. 2007, vol.70, n.4, pp. 649-655. ISSN 0004-2749.  http://dx.doi.org/10.1590/S0004-27492007000400016.

PURPOSE: To evaluate if oral flaxseed oil (Linum usitatissimum), which reduces the inflammation in rheumatoid arthritis, may help keratoconjunctivitis sicca's treatment in Sjögren's syndrome patients. METHODS: In a randomized clinical trial, 38 female patients with rheumatoid arthritis or systemic lupus erithematosus associated with keratoconjunctivitis sicca and Sjögren's syndrome were consecutively selected from patients of the Departament of Reumatology of the Amazonas University Hospital. Keratoconjunctivitis sicca diagnosis was based on a dry-eye symptom survey score (Ocular Surface Disease Index - OSDI®), Schirmer-I test, fluorescein break-up time, 1% Rose Bengal staining of ocular surface measured by the van Bijsterveld scale. All patients had ocular surface inflammation evaluated and quantified by conjunctival impression cytology, before and after the study. The subjects were divided into three groups with 13 (Group I), 12 (Group II) and 13 (Group III) patients. Group I received flaxseed oil capsules with a final 1 g/day dosis, Group II flaxseed oil capsules with a final 2 g/day dosis and Group III - controls - placebo, for 180 days. RESULTS: Comparing the results at the beginning and at the end of the treatment, statistically significant changes (p<0.05) in symptoms (OSDI®), ocular surface inflammation quantified by conjunctival impression cytology, Schirmer-I test and fluorescein break-up time occurred in Groups I e II when compared to controls. CONCLUSIONS: Therapy with oral flaxseed oil capsules 1 or 2 g/day reduces ocular surface inflammation and ameliorates the symptoms of keratoconjunctivitis sicca in Sjögren's syndrome patients. Long-term studies are needed to confirm the role of this therapy for keratoconjunctivitis sicca in Sjögren's syndrome.

Keywords : Dry eye syndromes; Keratoconjunctivitis sicca [drug therapy]; Flaxseed oil [therapeutic use]; Keratitis; Sjögren's syndrome; Tears [metabolism].

        · abstract in Portuguese     · text in Portuguese     · pdf in Portuguese